Application no. and date | 10075691.5 (espacenet) (Federated) (European Patent Register), 20050607 | Patent/reg. no. and date | DK/EP 2289872, 20170802 | Publication date | 20110302 | Priority no. and date | US 861923, 20040607, US 863524, 20040609, US 961380, 20041012 | EP pub. no. and date |
EP 2289872 20110302 | Effective date | | Applicant/owner | University of Tennessee Research Foundation, 211 Conference Center Building 600 Henley Street
Knoxville, TN 37996-4122, US | Applicant ref. no. | 62385DK01 | Inventor | Veverka, Karen, A., 669 Featherwind Cove S.
Cordova, Tennessee 38018, US, MILLER, Duane D., 1646 Forsythe Trail
Collierville, TN 38017, US, Dalton, James T., 3477 Wagner Woods Court
Ann Arbor, MI 48103, US, Kim, Juhyun, 3221 Pine Bluff Drive
Ellicott City, MD 21042, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/17 (2006.01) , A61K 31/663 (2006.01) , C07C 235/24 (2006.01) , C07C 255/60 (2006.01) | Title | Medicinsk anvendelse af en selektiv androgen receptor-modulator | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|